Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/20/2025

Management of Depression in Patients with Diabetic Ketoacidosis

Initial Management of DKA

  • The American Diabetes Association recommends continuous IV insulin infusion at 0.1 units/kg/hour to resolve ketoacidosis, regardless of glucose levels, as part of the acute treatment protocol for DKA 1, 2
  • Aggressive fluid resuscitation with isotonic saline at 15-20 mL/kg/hour initially is recommended for the treatment of DKA 1, 2
  • Electrolyte management, particularly potassium replacement once renal function is confirmed, is crucial in the management of DKA 1, 2
  • Treatment of precipitating causes such as infection, myocardial infarction, or medication effects is essential in the management of DKA 2

Post-DKA Antidepressant Selection

  • The American College of Clinical Endocrinologists recommends initiating an SSRI such as sertraline or citalopram as the first-line choice for antidepressant therapy after DKA has completely resolved (pH >7.3, bicarbonate ≥18 mEq/L, glucose <200 mg/dL, anion gap ≤12 mEq/L) 1, 2
  • SSRIs such as sertraline, citalopram, or escitalopram are preferred due to their minimal effects on glucose metabolism and weight, according to the American Diabetes Association 3

Critical Transition Protocol

  • The American Association of Clinical Endocrinologists recommends administering basal insulin (glargine or detemir) 2-4 hours BEFORE stopping the IV insulin infusion to prevent DKA recurrence and rebound hyperglycemia 1, 2
  • Continuous monitoring of glucose every 2-4 hours during the transition period from IV to subcutaneous insulin is recommended by the American Diabetes Association 1
  • Ensuring the patient can tolerate oral intake before starting any oral medications, including antidepressants, is crucial according to the American College of Clinical Endocrinologists 1

Discharge Planning and Follow-Up

  • The American Diabetes Association recommends scheduling outpatient follow-up within 1-2 weeks if glycemic control is not optimal at discharge 3
  • Initiating SSRI therapy only after metabolic stability is confirmed and the patient is tolerating oral intake is recommended by the American College of Clinical Endocrinologists 3
  • Providing patient education on sick day management and signs of DKA recurrence is essential according to the American Association of Clinical Endocrinologists 1

REFERENCES

1

Diabetic Ketoacidosis Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Assessment and Management of Diabetic Ketoacidosis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025